Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
Release Notes Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: INT260
MIFTS: 42

Intracranial Berry Aneurysm

Categories: Cardiovascular diseases, Genetic diseases, Neuronal diseases, Rare diseases
Data Licensing
For inquiries, contact:
[email protected]
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Intracranial Berry Aneurysm

About this section

MalaCards integrated aliases for Intracranial Berry Aneurysm:

Name: Intracranial Berry Aneurysm 11 14
Familial Aneurysmal Subarachnoid Hemorrhage 11
Familial Intracranial Saccular Aneurysm 11
Aneurysmal Subarachnoid Hemorrhage 14
Aneurysm, Intracranial Berry, 1 71
Aneurysm, Intracranial Berry 75
Saccular Cerebral Aneurysm 11
Familial Berry Aneurysm 11

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases
Anatomical: Cardiovascular diseases Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 11 DOID:0060228
UMLS 71 C1862932
Sources

Summaries for Intracranial Berry Aneurysm

About this section

Disease Ontology: 11 An intracranial aneurysm with a characteristic rounded shape; the most common form of cerebral aneurysm.

MalaCards based summary: Intracranial Berry Aneurysm, also known as familial aneurysmal subarachnoid hemorrhage, is related to stroke, ischemic and ischemia. An important gene associated with Intracranial Berry Aneurysm is ANIB1 (Aneurysm, Intracranial Berry 1), and among its related pathways/superpathways is HIF-1-alpha transcription factor network. The drugs Desflurane and Gabapentin have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and pituitary.

Wikipedia: 75 An intracranial aneurysm, also known as a brain aneurysm, is a cerebrovascular disorder in which... more...
Sources

Related Diseases for Intracranial Berry Aneurysm

About this section

Diseases in the Intracranial Berry Aneurysm family:

Aneurysm, Intracranial Berry, 1 Aneurysm, Intracranial Berry, 5
Aneurysm, Intracranial Berry, 2 Aneurysm, Intracranial Berry, 3
Aneurysm, Intracranial Berry, 4 Aneurysm, Intracranial Berry, 6
Aneurysm, Intracranial Berry, 7 Aneurysm, Intracranial Berry, 8
Aneurysm, Intracranial Berry, 9 Aneurysm, Intracranial Berry, 10
Aneurysm, Intracranial Berry, 11 Aneurysm, Intracranial Berry, 12

Diseases related to Intracranial Berry Aneurysm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 364)
# Related Disease Score Top Affiliating Genes
1 stroke, ischemic 32.4 SERPINA3 PLAT NOS3 MIR4793 ADM
2 ischemia 32.4 PLAT NOS3 HMOX1 EDN1 ADM
3 hypertension, essential 31.3 SERPINA3 PLAT PKD1 NOS3 HMOX1 EDN1
4 hemiplegia 31.2 S100B PLAT EDN1
5 migraine with or without aura 1 31.2 SERPINA3 S100B NOS3 EDN1 ADM
6 coronary artery vasospasm 31.1 NOS3 EDN1
7 myocardial infarction 31.1 SERPINA3 S100B PLAT NOS3 HMOX1 EDN1
8 cerebral artery occlusion 31.0 PLAT HMOX1 EDN1
9 intracranial vasospasm 31.0 S100B EDN1
10 pre-eclampsia 30.9 PLAT NOS3 HMOX1 EDN1 ADM
11 peripheral vascular disease 30.7 SERPINA3 PLAT NOS3 EDN1
12 renal hypertension 30.7 NOS3 EDN1 ADM
13 cardiovascular system disease 30.7 SERPINA3 PLAT NOS3 HMOX1 EDN1 ADM
14 acute myocardial infarction 30.7 PLAT NOS3 EDN1 ADM
15 hellp syndrome 30.7 PLAT EDN1 ADM
16 lipoprotein quantitative trait locus 30.6 SERPINA3 PLAT NOS3 EDN1 ADM
17 aneurysm, intracranial berry, 2 11.7
18 aneurysm, intracranial berry, 12 11.7
19 aneurysm, intracranial berry, 5 11.7
20 aneurysm, intracranial berry, 3 11.7
21 aneurysm, intracranial berry, 4 11.7
22 aneurysm, intracranial berry, 6 11.7
23 aneurysm, intracranial berry, 7 11.7
24 aneurysm, intracranial berry, 8 11.7
25 aneurysm, intracranial berry, 1 11.6
26 aneurysm, intracranial berry, 9 11.6
27 aneurysm, intracranial berry, 10 11.6
28 aneurysm, intracranial berry, 11 11.6
29 acquired aneurysmal subarachnoid hemorrhage 11.4
30 hydrocephalus 11.3
31 polycystic kidney disease 1 with or without polycystic liver disease 11.3
32 familial cerebral saccular aneurysm 11.3
33 ocular motor apraxia 11.1
34 hemorrhage, intracerebral 11.0
35 pulmonary edema 10.8
36 headache 10.8
37 hyperglycemia 10.8
38 broken heart syndrome 10.8
39 intracranial hypertension 10.8
40 oculodentodigital dysplasia 10.7
41 visual epilepsy 10.7
42 cerebrovascular disease 10.7
43 pituitary gland disease 10.6
44 body mass index quantitative trait locus 1 10.6
45 thrombophilia due to thrombin defect 10.6
46 ceroid lipofuscinosis, neuronal, 5 10.6
47 tatton-brown-rahman syndrome 10.6
48 urinary tract infection 10.6
49 traumatic brain injury 10.6
50 hypopituitarism 10.6

Graphical network of the top 20 diseases related to Intracranial Berry Aneurysm:



Diseases related to Intracranial Berry Aneurysm
Sources

Symptoms & Phenotypes for Intracranial Berry Aneurysm

About this section
Sources

Drugs & Therapeutics for Intracranial Berry Aneurysm

About this section

Drugs for Intracranial Berry Aneurysm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 152)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Desflurane Approved Phase 4 57041-67-5 42113
2
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
3
Acetazolamide Approved, Vet_approved Phase 4 59-66-5, 1424-27-7 1986
4
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
5
Huperzine A Approved, Experimental Phase 4 102518-79-6
6 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
7 diuretics Phase 4
8 Psychotropic Drugs Phase 4
9 Anti-Anxiety Agents Phase 4
10 Carbonic Anhydrase Inhibitors Phase 4
11 Bronchodilator Agents Phase 4
12 Anti-Asthmatic Agents Phase 4
13
Epoetin Alfa Phase 4
14 Hematinics Phase 4
15
Aluminum hydroxide Approved, Investigational Phase 3 21645-51-2
16
Levoleucovorin Approved, Experimental, Investigational Phase 3 68538-85-2, 58-05-9, 73951-54-9 149436 6006
17
Dapsone Approved, Investigational Phase 3 80-08-0 2955
18
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3 3680
19
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 3003 5743
20
Plasminogen Approved Phase 3 9001-91-6
21
Acetylcysteine Approved, Investigational Phase 3 616-91-1 581 12035
22
Acetaminophen Approved Phase 3 103-90-2 1983
23
Ketamine Approved, Vet_approved Phase 2, Phase 3 6740-88-1, 1867-66-9 3821
24
Nimodipine Approved, Investigational Phase 3 66085-59-4 4497
25
Propofol Approved, Investigational, Vet_approved Phase 3 2078-54-8 4943
26
Dexmedetomidine Approved, Experimental, Vet_approved Phase 3 86347-14-0, 113775-47-6 68602 5311068
27
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
28
Glutamic acid Approved, Nutraceutical Phase 3 56-86-0 33032
29
Cerebrolysin Experimental Phase 2, Phase 3 12656-61-0
30 Astragalus Phase 2, Phase 3
31 Neuroprotective Agents Phase 2, Phase 3
32 Immunologic Factors Phase 3
33 Adjuvants, Immunologic Phase 3
34 Folic Acid Antagonists Phase 3
35 Folate Phase 3
36 Anti-Ulcer Agents Phase 3
37 Vitamin B9 Phase 3
38 Antiprotozoal Agents Phase 3
39 Antiparasitic Agents Phase 3
40 Antacids Phase 3
41 Vitamin B Complex Phase 3
42 Antimalarials Phase 3
43 Tin Fluorides Phase 3
44 Fibrinolytic Agents Phase 3
45 Tissue Plasminogen Activator Phase 3
46 Anti-Inflammatory Agents Phase 3
47 Gastrointestinal Agents Phase 3
48 Antineoplastic Agents, Hormonal Phase 3
49 Hormone Antagonists Phase 3
50 Antiemetics Phase 3

Interventional clinical trials:

(show top 50) (show all 126)
# Name Status NCT ID Phase Drugs
1 The Role of Statins in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage Unknown status NCT01346748 Phase 4 statin
2 Comparison Of Pharmacological Neuroprotection Provided By PROPOFOL VERSUS DESFLURANE For Long Term Postoperative Cognitive Dysfunction In Patients Undergoing Surgery For Aneurysmal Subarachnoid Hemorrhage Completed NCT02987218 Phase 4 Propofol;Desflurane
3 Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage Completed NCT02330094 Phase 4 Gabapentin;Placebo
4 C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm Completed NCT03377049 Phase 4 Acetazolamide
5 Efficacy and Safety of Cilostazol-Nimodipine Combined Therapy on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage (aSAH): A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial Recruiting NCT04148105 Phase 4 Cilostazol 100 MG
6 The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study Not yet recruiting NCT05560373 Phase 4 Huperzine A injection, operational treatment, the best basic treatment;Huperzine A injection, interventional treatment, the best basic treatment
7 A Double Blinded, Placebo Controlled, Pilot Study to Evaluate the Safety of Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa Terminated NCT00626574 Phase 4 Epoetin alfa;Saline
8 Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage Withdrawn NCT01935908 Phase 4 levetiracetam
9 A Pilot Study of Sub-anesthetic Ketamine Infusion for Neuroprotection After Aneurysmal Subarachnoid Hemorrhage: Effects on White Matter Integrity, Inflammatory Biomarkers and Neurocognitive Outcome Unknown status NCT02636218 Phase 2, Phase 3 Ketamine;0.9% NaCl
10 Efficacy Study of Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage Unknown status NCT03271697 Phase 2, Phase 3 Astragalus Membranaceus;Placebo
11 A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping. Completed NCT00558311 Phase 3 Clazosentan;Placebo
12 Neuroprotective Effect of Dapsone in Patients With Aneurysmal Subarachnoid Hemorrhage: Prospective, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial Completed NCT05131295 Phase 3 Dapsone;Aluminum Hydroxide Gel
13 A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3 Study to Assess the Efficacy and Safety of Clazosentan in Preventing Clinical Deterioration Due to Delayed Cerebral Ischemia (DCI), in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage (aSAH) Completed NCT03585270 Phase 3 Clazosentan;Placebo
14 Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial Completed NCT02483351 Phase 2, Phase 3
15 EARLYdrain - Prospective Outcome Study of Early Lumbar Drainage in Aneurysmal Subarachnoid Hemorrhage Completed NCT01258257 Phase 3
16 Randomized, Double-blind, Placebo-controlled Pilot Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage Completed NCT01787123 Phase 2, Phase 3 Intravenous Cerebrolysin;Normal Saline
17 Intraventricular Fibrinolysis Versus External Ventricular Drainage Alone in Aneurysmal Subarachnoid Hemorrhage: a Randomized Controlled Trial. Recruiting NCT03187405 Phase 3 EVD + IVF with Alteplase
18 Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage Recruiting NCT05132920 Phase 3 Dexamethasone;Placebo
19 Inhibition of Lipid Peroxidation and Cerebral Vasospasm by an Acetaminophen-Based Regimen in Patients With Aneurysmal Subarachnoid Hemorrhage Active, not recruiting NCT00585559 Phase 3 Placebos for acetaminophen and N-acetylcysteine;APAP 1 gm every 6 hours and N-acetylcysteine placebo;NAC IV infusion at 0.5 gm hourly and APAP placebo;APAP 1 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly;APAP 1.5 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly
20 A Pilot Study of Ketamine Sedation Initiated Early After Aneurysmal Subarachnoid Hemorrhage: Effect on Vasospasm, Delayed Cerebral Ischemia, and Functional Outcomes Not yet recruiting NCT05032118 Phase 2, Phase 3 Ketamine Hydrochloride;Propofol
21 Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage Terminated NCT02790632 Phase 3 EG-1962 (nimodipine microparticles);Enteral Nimodipine
22 A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling. Terminated NCT00940095 Phase 3 Clazosentan 5 m/h;Clazosentan 15 mg/h;Placebo
23 Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage Terminated NCT01565590 Phase 3 Dexmedetomidine;propofol
24 Prevention of Secondary Ischemia After Aneurysmal Subarachnoid Hemorrhage With Cerebrospinal Fluid Drainage. A Randomized Controlled Trial Terminated NCT01407614 Phase 2, Phase 3
25 Hypertonic Saline Solution in Aneurysmal Subarachnoid Hemorrhage: A Randomized - Phase II Single Blinded Clinical Trial Unknown status NCT02432157 Phase 1, Phase 2 HTS 3%;Standard fluid management
26 Clevidipine in Aneurysmal Subarachnoid Hemorrhage, A Pilot Study Unknown status NCT00978822 Phase 2 Clevidipine butyrate injectable emulsion
27 Intraventricular Tissue Plasminogen Activator in the Management of Aneurysmal Subarachnoid Hemorrhage: a Randomized Controlled Pilot Study Unknown status NCT01098890 Phase 2 Tissue Plasminogen Activator;Placebo
28 Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial Unknown status NCT02875262 Phase 1, Phase 2 Deferoxamine
29 Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage Completed NCT01893190 Phase 1, Phase 2 Nimodipine;Nimodipine Microparticles
30 A Prospective, Multi-center, Open-label, Single-arm, Phase 2 Study to Assess the Efficacy and Safety of Clazosentan in Reversing Angiographically-confirmed Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage (aSAH) Treated by Surgical Clipping or Endovascular Coiling Completed NCT02560532 Phase 2 Clazosentan
31 Effects of Systemic Erythropoietin Therapy on Cerebral Autoregulation and Incidence of Delayed Ischemic Deficits in Patients With Aneurysmal Subarachnoid Hemorrhage Completed NCT00140010 Phase 2 erythropoietin beta
32 OSU6162 in the Treatment of Fatigue and Other Neuropsychological Sequelae After Aneurysmal Subarachnoid Hemorrhage - A Double-blind, Randomised, Placebo-controlled Study Completed NCT03209830 Phase 2 OSU 6162;Placebo Oral Tablet
33 Phase II Study of the Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage Completed NCT01095731 Phase 2 Tiopronin;Placebo
34 Single Escalating-dose, Open-label Study to Assess the Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) After Acute Aneurysmal Subarachnoid Hemorrhage (SAH) Completed NCT02323685 Phase 2
35 A Phase IIb, Multi-center, International, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding Study for the Prevention of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage (aSAH) by Intravenous Administration of Clazosentan, a Selective Endothelin A (ETA) Receptor Antagonist Completed NCT00111085 Phase 2 Clazosentan 1 mg/h;Clazosentan 5 mg/h;Clazosentan 15 mg/h;Placebo
36 A Phase 1/2a Exploratory Clinical Trial to Evaluate the Safety of Oral Deferiprone (14 Days) Including Its Effect on Decreasing the Content of Iron in Subjects With Aneurysmal Subarachnoid Hemorrhage (aSAH) sIRB Recruiting NCT03754725 Phase 1, Phase 2 Deferiprone pill;placebo
37 Preventative Treatment of Depression in Survivors of Aneurysmal Subarachnoid Hemorrhage Recruiting NCT03826875 Phase 2 Fluoxetine;Placebo
38 Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (DISH) Recruiting NCT04566991 Phase 2 Deferoxamine;Placebo
39 Efficacy of 10 Days Intravenous Milrinone Treatment to Optimize Cerebral Hemodynamic and Prevent Delayed Cerebral Ischemia (DCI) in Patients With Severe Subarachnoid Hemorrhage Due to Intracranial Aneurysm Rupture Recruiting NCT04282629 Phase 2 Milrinone Injection
40 Effect of Inhalatory Sedation on Cerebral Perfusion in Subarachnoid Hemorrhage Recruiting NCT05213832 Phase 2 Isoflurane Inhal Soln
41 Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine Recruiting NCT04507178 Phase 2 Nadroparin Injectable Product
42 Minocycline as a Neuroprotective Agent Against Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Active, not recruiting NCT04876638 Phase 2 Minocyclin
43 A Phase IIb: Randomised, Single-Blind, Safety, Tolerability, Efficacy and Pharmacokinetic Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping Active, not recruiting NCT04269408 Phase 2 Nicardipine
44 Effect of Xenon on Brain Injury, Neurological Outcome and Survival in Patients After Aneurysmal Subarachnoid Hemorrhage Not yet recruiting NCT04696523 Phase 2 Xenon;air/oxygen
45 A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden Suspended NCT02501434 Phase 2 Continuous Low-Dose IV Unfractionated Heparin Infusion
46 Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Terminated NCT02712788 Phase 2 Milrinone;Placebo
47 Safety and Efficacy of Cervical Sympathetic Block in Patients With Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage - Pilot Study Terminated NCT00930072 Phase 2 Cervical Sympathetic Block (bupivicaine, clonidine)
48 Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage Terminated NCT02222727 Phase 2 Donepezil
49 Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Withdrawn NCT01878136 Phase 1, Phase 2 Tissue Plasminogen Activator
50 Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage Withdrawn NCT02113176 Phase 1, Phase 2 Minocycline

Search NIH Clinical Center for Intracranial Berry Aneurysm

Sources

Genetic Tests for Intracranial Berry Aneurysm

About this section
Sources

Anatomical Context for Intracranial Berry Aneurysm

About this section

Organs/tissues related to Intracranial Berry Aneurysm:

MalaCards : Brain, Spinal Cord, Pituitary, Endothelial, Neutrophil, Smooth Muscle, Kidney
Sources

Publications for Intracranial Berry Aneurysm

About this section

Articles related to Intracranial Berry Aneurysm:

(show top 50) (show all 5096)
# Title Authors PMID Year
1
Endothelial nitric oxide synthase tagging single nucleotide polymorphisms and recovery from aneurysmal subarachnoid hemorrhage. 53 62
19419976 2009
2
Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. 53 62
18309169 2008
3
Role of endothelial nitric oxide synthase gene polymorphisms in predicting aneurysmal subarachnoid hemorrhage in South Indian patients. 53 62
18688082 2008
4
Update on evidence for a genetic predisposition to cerebral vasospasm. 53 62
17029342 2006
5
Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. 53 62
15967223 2005
6
Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. 53 62
16265315 2004
7
Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. 53 62
15686175 2004
8
Section on cerebrovascular surgery: Galbraith Award: Endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1) gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage (SAH) and post-SAH cerebral vasospasm. 53 62
15571165 2004
9
Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. 53 62
11340231 2001
10
Increase and uncoupling of adrenomedullin from the natriuretic peptide system in aneurysmal subarachnoid hemorrhage. 53 62
11213962 2001
11
Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. 53 62
11108778 2000
12
Endothelin in cerebral vasospasm. Clinical and experimental results. 53 62
9385564 1997
13
Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm. 53 62
8718759 1996
14
[Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm]. 53 62
7566413 1995
15
Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. 53 62
7815135 1995
16
A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. 53 62
7808602 1994
17
Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. 53 62
8052377 1994
18
The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. 53 62
1607979 1992
19
Advances in Intracranial Hemorrhage: Subarachnoid Hemorrhage and Intracerebral Hemorrhage. 62
36333038 2023
20
Development of a questionnaire to identify persons with a family history of aneurysmal subarachnoid hemorrhage. 62
35014571 2022
21
The prognostic value of hyperglycemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. 62
36169785 2022
22
Systematic review and meta-analysis of outcome-relevant anemia in patients with subarachnoid hemorrhage. 62
36456587 2022
23
Risk Factors for Delayed Cerebral Ischemia in Good-Grade Patients With Aneurysmal Subarachnoid Hemorrhage. 62
36444866 2022
24
A Systematic Review of Inflammatory Cytokine Changes Following Aneurysmal Subarachnoid Hemorrhage in Animal Models and Humans. 62
35260989 2022
25
Letter: Development and Internal Validation of the ARISE Prediction Models for Rebleeding After Aneurysmal Subarachnoid Hemorrhage. 62
36255183 2022
26
The value of comorbidities and illness severity scores as prognostic tools for early outcome estimation in patients with aneurysmal subarachnoid hemorrhage. 62
36367594 2022
27
Use of A Systemic Inflammatory Response Index to Predict Non-Traumatic Non-Aneurysmal Subarachnoid Hemorrhage Patient Outcomes. 62
36323168 2022
28
Transcranial Doppler and computed tomography angiography for detecting cerebral vasospasm post-aneurysmal subarachnoid hemorrhage. 62
36471088 2022
29
Elevated N-terminal pro-brain-type natriuretic peptide at admission is associated with unfavorable outcomes after aneurysmal subarachnoid hemorrhage. 62
36228503 2022
30
Bispectral index monitoring to detect delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. 62
36152563 2022
31
C-Terminal Proarginine Vasopressin is Associated with Disease Outcome and Mortality, but not with Delayed Cerebral Ischemia in Critically Ill Patients with an Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study. 62
35750931 2022
32
Longitudinal neuropsychological assessment after aneurysmal subarachnoid hemorrhage and its relationship with delayed cerebral ischemia: a prospective Swiss multicenter study. 62
35535839 2022
33
NT-proBNP and troponin I in high-grade aneurysmal subarachnoid hemorrhage: Relation to clinical course and outcome. 62
35908328 2022
34
Association of asymptomatic cerebral vasospasm with outcomes in survivors of aneurysmal subarachnoid hemorrhage. 62
36240674 2022
35
Elevated blood viscosity is associated with delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. 62
36201988 2022
36
Commentary: Serum Levels of Myo-inositol Predicts Clinical Outcome 1 Year After Aneurysmal Subarachnoid Hemorrhage. 62
36269571 2022
37
Decrease in cortical vein opacification predicts outcome after aneurysmal subarachnoid hemorrhage. 62
36456184 2022
38
Tranexamic acid for patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of 2991 patients. 62
36463556 2022
39
Effect of antiplatelet treatment on aneurysmal subarachnoid hemorrhage patients after endovascular treatment: a systematic review with meta-analysis. 62
36178562 2022
40
Blood pressure and the risk of rebleeding and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. 62
36208555 2022
41
Intracranial Pressure Monitoring Practice, Treatment, and Effect on Outcome in Aneurysmal Subarachnoid Hemorrhage. 62
36471182 2022
42
Early Systemic Glycolytic Shift After Aneurysmal Subarachnoid Hemorrhage is Associated with Functional Outcomes. 62
35799091 2022
43
Revisiting the Timeline of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Toward a Temporal Risk Profile. 62
35790670 2022
44
Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. 62
35364589 2022
45
Meta-analysis of associations of genetic polymorphisms with cerebral vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. 62
34725794 2022
46
Prospective assessment of aneurysmal rupture risk scores in patients with subarachnoid hemorrhage: a multicentric cohort. 62
35695927 2022
47
Antiplatelet therapy for standalone coiling of ruptured intracranial aneurysms: a systematic review and meta-analysis. 62
35101959 2022
48
The Potential Role of Neuromodulation in Subarachnoid Hemorrhage. 62
35088724 2022
49
Heparin infusions in aneurysmal subarachnoid hemorrhages: clinical considerations for use beyond anticoagulation. 62
36377793 2022
50
A Systematic Review of Neuropsychological Outcomes After Treatment of Intracranial Aneurysms. 62
36239513 2022
Sources

Variations for Intracranial Berry Aneurysm

About this section
Sources

Expression for Intracranial Berry Aneurysm

About this section
Search GEO for disease gene expression data for Intracranial Berry Aneurysm.
Sources

Pathways for Intracranial Berry Aneurysm

About this section

Pathways related to Intracranial Berry Aneurysm according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
HIF-1-alpha transcription factor network 61
10.61 HMOX1 EDN1 ADM
Sources

GO Terms for Intracranial Berry Aneurysm

About this section

Biological processes related to Intracranial Berry Aneurysm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of blood pressure GO:0008217 9.8 NOS3 HMOX1 EDN1
2 response to hypoxia GO:0001666 9.8 PLAT HMOX1 EDN1 ADM
3 cellular response to follicle-stimulating hormone stimulus GO:0071372 9.67 PLAT EDN1
4 response to fluid shear stress GO:0034405 9.56 PKD1 NOS3
5 cellular response to luteinizing hormone stimulus GO:0071373 9.46 PLAT EDN1
6 regulation of systemic arterial blood pressure by endothelin GO:0003100 9.26 NOS3 EDN1
7 smooth muscle hyperplasia GO:0014806 8.92 NOS3 HMOX1
Sources

Sources for Intracranial Berry Aneurysm

About this section
2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....